"It's incredible, and a big surprise, that the same infection that caused so much devastation can help create a ...
Live Science on MSN1d
Severe COVID-19 may shrink cancer tumors, early data suggestImmune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...
InflaRx (IFRX) has released an update. InflaRx has received a positive opinion from the European Medicines Agency’s CHMP for GOHIBIC, a ...
Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...
A clinical trial of 52 people with long Covid who were prescribed low doses of lithium aspartate revealed that it failed to ...
The risks of thromboembolism—blood clots blocking blood flow to organs—following COVID-19 vaccination in patients with atrial ...
New research from Northwestern Medicine shows that in some cases of severe COVID, the immune response actually killed cancer cells. Researchers are trying to harness that immune power into new cancer ...
Discover how COVID-19 triggers the development of unique immune cells with anti-cancer properties, offering hope for new cancer treatment options.
Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback